Schedule 13G ownership disclosure
Ceribell Inc
Common Stock, $0.001 par value per share · CUSIP: 15678C102
Event date: 2024-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- ABG WTT-Ceribell Limited
Shares: 2,441,267.00 · Class: 6.8%
- ABG V-Ceribell Limited
Shares: 2,441,267.00 · Class: 6.8%
- Ally Bridge Group Global Life Science Capital Partners V, L.P.
Shares: 2,441,267.00 · Class: 6.8%
- ABG Global Life Science Capital Partners V GP, L.P.
Shares: 2,441,267.00 · Class: 6.8%
- ABG Global Life Science Capital Partners V GP Limited
Shares: 2,441,267.00 · Class: 6.8%
- Ally Bridge Group-WTT Global Life Science Capital Partners, L.P.
Shares: 2,441,267.00 · Class: 6.8%
- ABG-WTT Global Life Science Capital Partners GP, L.P.
Shares: 2,441,267.00 · Class: 6.8%
- ABG-WTT Global Life Science Capital Partners GP Limited
Shares: 2,441,267.00 · Class: 6.8%
- ABG Management Ltd.
Shares: 2,441,267.00 · Class: 6.8%
- Ally Bridge Group (PE) LLC
Shares: 2,441,267.00 · Class: 6.8%
- Fan Yu
Shares: 2,441,267.00 · Class: 6.8%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000919574-25-002726
- Form type
- SCHEDULE 13G
- Filer
- ABG Management Ltd.
- CIK
- CIK 1832106
- Filed
- May 02, 2025
- Reporting period
- Dec 31, 2024
- Description
- Schedule 13G beneficial ownership